Cocrystal Pharma (COCP) Non-Current Debt (2010 - 2013)

Cocrystal Pharma (COCP) has 4 years of Non-Current Debt data on file, last reported at $2.9 million in Q3 2013.

• For the quarter ending Q3 2013, Non-Current Debt rose 0.56% year-over-year to $2.9 million; the trailing twelve-month figure through Sep 2013 stood at $2.9 million (up 0.56% YoY), and the FY2012 full-year result was $3.1 million, down 6.73% from the prior year.
• Non-Current Debt advanced to $2.9 million in Q3 2013, from $2.9 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $3.3 million in Q4 2011 to a low of $2.9 million in Q2 2013.
• A 4-year average of $3.1 million and a median of $3.1 million in 2012 frame the typical range for Non-Current Debt.
• Across the five-year window, Non-Current Debt advanced 8.35% in 2011 and declined 8.52% in 2013, its largest moves.
• Tracing COCP's Non-Current Debt over 4 years: stood at $3.0 million in 2010, then climbed by 8.35% to $3.3 million in 2011, then fell by 6.73% to $3.1 million in 2012, then dropped by 4.77% to $2.9 million in 2013.
• Business Quant data shows COCP's Non-Current Debt at $2.9 million in Q3 2013, $2.9 million in Q2 2013, and $3.2 million in Q1 2013.